Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Evaluating credit card rewards is crucial for maximizing value. Learn which options provide the best returns for your spending.
28,180 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
A small-cap memory-interface provider, Lumina IP, reports gross margins near 80% in Q1 2026 as AI accelerators push d...
As remote work persists, demand for ranch and winery estates on California’s Central Coast has shifted from leisure t...
ASML sits at the core of modern chipmaking. This article examines whether asml stock undervalued semiconductor opport...
Harmony Gold Mining Stock slid about 12% over the week as gold prices cooled and rate expectations shifted. This arti...
Investing in biotech can be bold. This piece lays out practical scenarios for what much could $1,000 invested in Viki...
Microsoft is at a crossroads as investors await the July 29 results. This article dives into why the stock could rebo...
Planet Labs leads a broad space sector rally, with Rocket Lab and SpaceX climbing alongside space-focused ETFs as inv...
Natera shows growth through AI-enabled cell-free DNA tests and a widening data moat, positioning it as a leading nate...
United Natural Foods stock dropped after the latest earnings release, signaling a mix of revenue challenges and margi...
CrowdStrike is approaching a stock split, but smart investors look beyond the headline. Here are three solid reasons ...
Three legacy tech giants are pushing new strategies in 2026 as investors weigh durable enterprise moats against consu...